Similar articles for PMID: 35294377

Year	Number of Results
1974	1
1982	1
1985	2
1989	2
1998	1
2004	1
2005	1
2008	1
2009	1
2010	1
2011	3
2012	8
2013	2
2014	2
2015	9
2016	10
2017	7
2018	2
2019	11
2020	12
2021	6
2022	1
2023	3
2024	0

1

Key Factors Influencing Use of Immunization Cost Evidence in Country Planning and Budgeting Processes: Experiences From Indonesia, Tanzania, and Vietnam.

Ozaltin A, Vaughan K, Tani K, Manzi F, Mai VQ, Van Minh H, Kosen S, Shimp L, Brenzel L, Boonstoppel L. Ozaltin A, et al. Glob Health Sci Pract. 2022 Feb 28;10(1):e2100264. doi: 10.9745/GHSP-D-21-00264. Print 2022 Feb 28. Glob Health Sci Pract. 2022. PMID: 35294377 Free PMC article.

2

Immunization costs, from evidence to policy: Findings from a nationally representative costing study and policy translation effort in Tanzania.

Vaughan K, Clarke-Deelder E, Tani K, Lyimo D, Mphuru A, Manzi F, Schütte C, Ozaltin A. Vaughan K, et al. Vaccine. 2020 Nov 10;38(48):7659-7667. doi: 10.1016/j.vaccine.2020.10.004. Epub 2020 Oct 17. Vaccine. 2020. PMID: 33077300 Free PMC article.

3

The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh.

Teerawattananon Y, Tantivess S, Yamabhai I, Tritasavit N, Walker DG, Cohen JT, Neumann PJ. Teerawattananon Y, et al. Health Res Policy Syst. 2016 Dec 3;14(1):86. doi: 10.1186/s12961-016-0156-6. Health Res Policy Syst. 2016. PMID: 27912780 Free PMC article.

4

Design, Development, and Deployment of an Electronic Immunization Registry: Experiences From Vietnam, Tanzania, and Zambia.

Carnahan E, Nguyen L, Dao S, Bwakya M, Mtenga H, Duong H, Mwansa FD, Bulula N, Dang H, Rivera M, Nguyen T, Ngo T, Nguyen D, Werner L, Nguyen N. Carnahan E, et al. Glob Health Sci Pract. 2023 Feb 28;11(1):e2100804. doi: 10.9745/GHSP-D-21-00804. Print 2023 Feb 28. Glob Health Sci Pract. 2023. PMID: 36853635 Free PMC article.

5

Questions for future evidence-informed policy initiatives: insights from the evolution and aspirations of National Immunization Technical Advisory Groups.

Buffardi AL, Njambi-Szlapka S. Buffardi AL, et al. Health Res Policy Syst. 2020 Apr 22;18(1):40. doi: 10.1186/s12961-020-00551-7. Health Res Policy Syst. 2020. PMID: 32321521 Free PMC article.

6

The future of Cochrane Neonatal.

Soll RF, Ovelman C, McGuire W. Soll RF, et al. Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834

7

Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe.

Blau J, Hoestlandt C, D Clark A, Baxter L, Felix Garcia AG, Mounaud B, Mosina L. Blau J, et al. Vaccine. 2015 May 7;33 Suppl 1:A34-9. doi: 10.1016/j.vaccine.2014.12.073. Vaccine. 2015. PMID: 25919171

8

The challenge of bridging the gap between researchers and policy makers: experiences of a Health Policy Research Group in engaging policy makers to support evidence informed policy making in Nigeria.

Uzochukwu B, Onwujekwe O, Mbachu C, Okwuosa C, Etiaba E, Nyström ME, Gilson L. Uzochukwu B, et al. Global Health. 2016 Nov 4;12(1):67. doi: 10.1186/s12992-016-0209-1. Global Health. 2016. PMID: 27809862 Free PMC article.

9

A multi-country study of dengue vaccination strategies with Dengvaxia and a future vaccine candidate in three dengue-endemic countries: Vietnam, Thailand, and Colombia.

Lee JS, Lourenço J, Gupta S, Farlow A. Lee JS, et al. Vaccine. 2018 Apr 19;36(17):2346-2355. doi: 10.1016/j.vaccine.2018.03.002. Epub 2018 Mar 21. Vaccine. 2018. PMID: 29573874

10

Cost-Effectiveness and Affordability of Interventions, Policies, and Platforms for the Prevention and Treatment of Mental, Neurological, and Substance Use Disorders.

Levin C, Chisholm D. Levin C, et al. In: Patel V, Chisholm D, Dua T, Laxminarayan R, Medina-Mora ME, editors. Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2016 Mar 14. Chapter 12. In: Patel V, Chisholm D, Dua T, Laxminarayan R, Medina-Mora ME, editors. Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2016 Mar 14. Chapter 12. PMID: 27227237 Free Books & Documents. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 35294377

80 results

Results by year